Ventilation Tubes in Middle Ear Effusion Post-Nasopharyngeal Carcinoma Radiation: To Insert or Not?
Yehuda Schwarz, MD; Mayuri Manogaran; Sam J. Daniel, MD, MSc, FRCSC BACKGROUND Postirradiation otitis media with effusion (OME) due to transient edema and dysfunction of the eustachian tube is the most common radiotherapy-associated otologic complication in nasopharyngeal cancer (NPC) patients. However, it can be seen in other head and neck cancers whose field of radiation includes the nasopharynx. Whether to insert ventilation tubes in these patients remains controversial. On one hand, ventilation tube insertion may lead to persistent otorrhea and permanent ear drum perforation; on the other hand, patients left with their serous otitis may experience hearing loss, aural fullness, tinnitus and dizziness. What is the best practice when dealing with middle ear serous effusion post radiotherapy? This review focuses on NPC (Table I) , as this is the population in which radiation and ventilation tube insertion has been studied, but we feel the findings have widespread applicability in head and neck cancer.
LITERATURE REVIEW
A prospective controlled trial, involving 108 patients with NPC and OME before radiation therapy, randomized patients into two groups and assessed hearing. One group was observed whereas the other received ventilation tubes. Pure-tone audiometry testing was performed before radiation, after radiation, and then at serial intervals up to 4 years, measuring air-conduction thresholds and air-bone gaps at different intervals. The conclusion was that there was no hearing benefit from inserting ventilation tubes before radiotherapy. Hearing threshold changes were not significantly different between the two groups, and although both groups had air-bone gap improvement, the air-bone gap was not significantly different between the two groups. In addition, the probability of closing the air bone gap did not change with the insertion of tubes. 1 A prospective quasirandomized study of 96 patients with OME after radiotherapy for nasopharyngeal carcinoma were divided into three management groups: simple eardrum puncture plus aspiration, tympanic membrane fenestration with cauterization, and myringotomy plus grommet insertion. All patients were free of otologic symptoms before radiotherapy and were followed for 2 years.
2 Cure rates of OME and incidence of complications with each management method were assessed, where cure criteria included disappearance of aural fullness, absence of endoscopic evidence of middle ear fluid, and having a type A tympanogram. Seventeen ears (37.8%) were cured in the first group by the end of the follow-up. Complications included in decreasing frequency: persistent fluid, chronic suppurative otitis media, and a dry eardrum perforation. In the second group, 21 ears (46.7%) were cured by the end of the follow-up, with the complications in decreasing frequency being persistent fluid, dry eardrum perforation, and chronic suppurative otitis media. Twenty-three ears (51.1%) were cured in group three by the end of the follow-up. Complications encountered in decreasing order of frequency were: persistent fluid, chronic suppurative otitis media, dry eardrum perforation, and eardrum perforation with effusion. The conclusion was that treatment should begin with paracentesis, and that other methods should only be considered with failure of the latter. 2 A randomized prospective trial of 115 patients with nasopharyngeal carcinoma allocated patients to two groups before the initiation of radiotherapy; one group received ventilation tubes, and the other did not. The patients were followed for 6 months, assessing conductive and sensorineural hearing loss following radiotherapy and progression of tinnitus. Pure-tone audiograms before and after radiotherapy were used to measure changes in both air-bone gaps and sensorineural thresholds. Tinnitus was assessed subjectively (asking patient for its presence). There was a significant improvement in conductive hearing after the insertion of tubes. A small but significant mild (3dB) sensorineural hearing loss after 6 months, was found in the non tube group. The ventilation tubes also led to a significant improvement in symptoms of tinnitus. The study recommendation was to routinely insert ventilation tubes before initiating radiotherapy. 3 The benefit of tube insertion was attributed to the release of the negative pressure caused by eustachian tube dysfunction. The drawback to this study was the relatively short follow-up period (6 months) and the lack of a group undergoing paracentesis, which might have provided sufficient improvement.
A 10-year retrospective study of 67 survivors of NPC who received radiation therapy, included 100 ears, 40 of which had ventilation tubes and 60 of which had repeated myringotomies with aspiration. The study assessed postirradiated OME, chronic otitis media, and hearing levels (air conduction and bone conduction) by having each patient undergo either computed tomography (CT) or magnetic resonance imaging (MRI), audiometric evaluation, and physical exam before and after radiotherapy. The end result was that 90% of the tubed ears developed complications (chronic otitis media and middle ear effusion) compared to only 33% of the myringotomized ears. The patients with ventilation tubes experienced deterioration in both air and bone conduction after 10 years. The conclusion of the study was that insertion of ventilation tubes is contraindicated in postirradiated OME. 4 Eighty-five NPC patients with OME after primary chemoradiotherapy were prospectively enrolled in a study, where those cured of NPC were followed every 4 to 6 weeks with a mean follow-up of over 2 years. The study assessed resolution of OME between patients with and without the latter before radiotherapy, and OME resolution rates between those receiving conservative treatment, tympanostomy with aspiration, or grommet insertion. Resolution of OME was defined as the absence of signs or symptoms of OME and the presence of a dry intact tympanic membrane for 2 months. A stepwise management strategy was applied, where the initial treatment was conservative, with nasal irrigation (to improve nasal hygiene) and hearing aids for those with severe hearing loss. If symptoms persisted, myringotomy and aspiration was performed. Finally, for those with persistent OME, not responding to repeated myringotomies for at least 3 months, ventilation tube insertion was considered [5] . Most patients preferred immediate symptom relief with either myringotomy or ventilation tube insertion to conservative management. The incidence of developing discharging ears was highest in the ventilation tube group and lowest in the myringotomy with aspiration group. There was no significant difference in the rate of resolution of OME among the patients of different groups. 5 The drawback to this study was that all but four patients received neoadjuvant or concomitant chemotherapy.
BEST PRACTICE SUMMARY
A gradual approach to the management of OME postradiotherapy is recommended. The initial management should be conservative, with observation and the use of hearing aids if hearing loss is significant. If OME symptoms persist, paracentesis should be performed, with insertion of ventilation tubes (being aware of complications) reserved for patients with persistent symptoms.
LEVELS OF EVIDENCE
Two level 1b, two level 2b, and one level 3b articles are included in this best practice review. There are several other studies in the literature regarding this issue; however, we cited these as the best representatives.
